Mediwound Ltd expected to post a loss of 76 cents a share - Earnings Preview
Mediwound Ltd expected to post a loss of 76 cents a share - Earnings Preview
Mediwound Ltd MDWD.OQ MDWD.O is expected to show a fall in quarterly revenue when it reports results on August 13 for the period ending June 30 2026
The Yavne Central(hamerkaz)-based company is expected to report a 54.7% decrease in revenue to $2.588 million from $5.71 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
LSEG's mean analyst estimate for Mediwound Ltd is for a loss of 76 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Mediwound Ltd is $31.00, about 124.2% above its last closing price of $13.83
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | -0.65 | -0.65 | -0.23 | Beat | 64.9 |
Dec. 31 2026 | -0.67 | -0.63 | -0.56 | Beat | 11.3 |
Sep. 30 2025 | -0.73 | -0.81 | -0.24 | Beat | 70.4 |
Jun. 30 2025 | -0.56 | -0.57 | -1.23 | Missed | -115.2 |
Mar. 31 2025 | -0.66 | -0.66 | -0.07 | Beat | 89.4 |
Dec. 31 2024 | -0.59 | -0.61 | -0.36 | Beat | 40.7 |
Sep. 30 2024 | -0.45 | -0.44 | -0.98 | Missed | -121.1 |
Jun. 30 2024 | -0.43 | -0.42 | -0.68 | Missed | -61.9 |
This summary was machine generated August 11 at 12:57 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Mediwound
See all newsBrief: Mediwound Awarded Additional $3.3 Million From U.S. Department Of War To Advance Room-Temperature-Stable Formulation Of Nexobrid
Mediwound Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's MediWound beats Q2 revenue estimates, reaffirms 2026 guidance
Brief: MediWound Q2 EPS USD -0.57
Mediwound Ltd expected to post a loss of 76 cents a share - Earnings Preview